Mishchenko, O.Y. , Adonkina, V.Y. and Greshko, I.I. 2025. The substantiation of the cost optimization for ER(+) HER2(−) breast cancer hormone therapy based on the results of the cost minimization pharmacoeconomic analysis. Social Pharmacy in Health Care. 11, 1 (May 2025), 72–79. DOI:https://doi.org/10.24959/sphhcj.25.349.